α-adrenergic blocking properties of quinine HCl

Thomas E. Mecca, Janet T. Elam, Clinton B. Nash, Robert William Caldwell

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In the anesthetized dog, quinine HCl (50 mg/kg, i.v.) infused over a 20 min period produced a 22% maximum decrease in diastolic blood pressure, a 53% increase in pulse pressure and a 52% increase in myocardial contractile force. The initial positive inotropic response was maximal in the first 5-15 min of the quinine infusion and decreased to near control levels 40 min following the quinine infusion. Quinine caused a marked reduction in the noradrenaline (NA) pressor response, blockade of the adrenaline (A) pressor response, partial blunting of the angiotensin II (AII) pressor effect but no change in the depressor effect of isoprenaline (I). The positive inotropic effects of CaCl2 were reduced and the duration of contractile action to both I and CaCl2 was significantly prolonged by quinine. In isolated rabbit thoracic aortic strips, quinine produced a parallel, dose-related shift of the concentration-response curve for NA to the right but did not affect the maximum responses. A pA2 of 4.91 was estimated by the method of Schild. The determined line had a slope of -0.84 which is similar to a theoretical slope of -1.0 and indicates a direct relationship between the number of receptors occupied and the contractile response. The responses to AII and histamine (H) were not altered by quinine. These results suggest that quinine HCl produces α-adrenergic blockade; additionally, quinine modifies catecholamine- and calcium-induced myocardial contractile force responses.

Original languageEnglish (US)
Pages (from-to)159-166
Number of pages8
JournalEuropean Journal of Pharmacology
Volume63
Issue number2-3
DOIs
StatePublished - May 2 1980
Externally publishedYes

Fingerprint

Quinine
Adrenergic Agents
Blood Pressure
Angiotensin II
Norepinephrine
Isoproterenol
Histamine
Epinephrine
Catecholamines
Thorax
Dogs
Rabbits
Calcium

Keywords

  • Anesthetized dogs
  • Contractility
  • Quinine
  • Vasculature
  • α-Adrenergic blockade

ASJC Scopus subject areas

  • Pharmacology

Cite this

α-adrenergic blocking properties of quinine HCl. / Mecca, Thomas E.; Elam, Janet T.; Nash, Clinton B.; Caldwell, Robert William.

In: European Journal of Pharmacology, Vol. 63, No. 2-3, 02.05.1980, p. 159-166.

Research output: Contribution to journalArticle

Mecca, Thomas E. ; Elam, Janet T. ; Nash, Clinton B. ; Caldwell, Robert William. / α-adrenergic blocking properties of quinine HCl. In: European Journal of Pharmacology. 1980 ; Vol. 63, No. 2-3. pp. 159-166.
@article{52c7eadd1a6d4096b99cfa2c6bf2e395,
title = "α-adrenergic blocking properties of quinine HCl",
abstract = "In the anesthetized dog, quinine HCl (50 mg/kg, i.v.) infused over a 20 min period produced a 22{\%} maximum decrease in diastolic blood pressure, a 53{\%} increase in pulse pressure and a 52{\%} increase in myocardial contractile force. The initial positive inotropic response was maximal in the first 5-15 min of the quinine infusion and decreased to near control levels 40 min following the quinine infusion. Quinine caused a marked reduction in the noradrenaline (NA) pressor response, blockade of the adrenaline (A) pressor response, partial blunting of the angiotensin II (AII) pressor effect but no change in the depressor effect of isoprenaline (I). The positive inotropic effects of CaCl2 were reduced and the duration of contractile action to both I and CaCl2 was significantly prolonged by quinine. In isolated rabbit thoracic aortic strips, quinine produced a parallel, dose-related shift of the concentration-response curve for NA to the right but did not affect the maximum responses. A pA2 of 4.91 was estimated by the method of Schild. The determined line had a slope of -0.84 which is similar to a theoretical slope of -1.0 and indicates a direct relationship between the number of receptors occupied and the contractile response. The responses to AII and histamine (H) were not altered by quinine. These results suggest that quinine HCl produces α-adrenergic blockade; additionally, quinine modifies catecholamine- and calcium-induced myocardial contractile force responses.",
keywords = "Anesthetized dogs, Contractility, Quinine, Vasculature, α-Adrenergic blockade",
author = "Mecca, {Thomas E.} and Elam, {Janet T.} and Nash, {Clinton B.} and Caldwell, {Robert William}",
year = "1980",
month = "5",
day = "2",
doi = "10.1016/0014-2999(80)90439-2",
language = "English (US)",
volume = "63",
pages = "159--166",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - α-adrenergic blocking properties of quinine HCl

AU - Mecca, Thomas E.

AU - Elam, Janet T.

AU - Nash, Clinton B.

AU - Caldwell, Robert William

PY - 1980/5/2

Y1 - 1980/5/2

N2 - In the anesthetized dog, quinine HCl (50 mg/kg, i.v.) infused over a 20 min period produced a 22% maximum decrease in diastolic blood pressure, a 53% increase in pulse pressure and a 52% increase in myocardial contractile force. The initial positive inotropic response was maximal in the first 5-15 min of the quinine infusion and decreased to near control levels 40 min following the quinine infusion. Quinine caused a marked reduction in the noradrenaline (NA) pressor response, blockade of the adrenaline (A) pressor response, partial blunting of the angiotensin II (AII) pressor effect but no change in the depressor effect of isoprenaline (I). The positive inotropic effects of CaCl2 were reduced and the duration of contractile action to both I and CaCl2 was significantly prolonged by quinine. In isolated rabbit thoracic aortic strips, quinine produced a parallel, dose-related shift of the concentration-response curve for NA to the right but did not affect the maximum responses. A pA2 of 4.91 was estimated by the method of Schild. The determined line had a slope of -0.84 which is similar to a theoretical slope of -1.0 and indicates a direct relationship between the number of receptors occupied and the contractile response. The responses to AII and histamine (H) were not altered by quinine. These results suggest that quinine HCl produces α-adrenergic blockade; additionally, quinine modifies catecholamine- and calcium-induced myocardial contractile force responses.

AB - In the anesthetized dog, quinine HCl (50 mg/kg, i.v.) infused over a 20 min period produced a 22% maximum decrease in diastolic blood pressure, a 53% increase in pulse pressure and a 52% increase in myocardial contractile force. The initial positive inotropic response was maximal in the first 5-15 min of the quinine infusion and decreased to near control levels 40 min following the quinine infusion. Quinine caused a marked reduction in the noradrenaline (NA) pressor response, blockade of the adrenaline (A) pressor response, partial blunting of the angiotensin II (AII) pressor effect but no change in the depressor effect of isoprenaline (I). The positive inotropic effects of CaCl2 were reduced and the duration of contractile action to both I and CaCl2 was significantly prolonged by quinine. In isolated rabbit thoracic aortic strips, quinine produced a parallel, dose-related shift of the concentration-response curve for NA to the right but did not affect the maximum responses. A pA2 of 4.91 was estimated by the method of Schild. The determined line had a slope of -0.84 which is similar to a theoretical slope of -1.0 and indicates a direct relationship between the number of receptors occupied and the contractile response. The responses to AII and histamine (H) were not altered by quinine. These results suggest that quinine HCl produces α-adrenergic blockade; additionally, quinine modifies catecholamine- and calcium-induced myocardial contractile force responses.

KW - Anesthetized dogs

KW - Contractility

KW - Quinine

KW - Vasculature

KW - α-Adrenergic blockade

UR - http://www.scopus.com/inward/record.url?scp=0018836810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018836810&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(80)90439-2

DO - 10.1016/0014-2999(80)90439-2

M3 - Article

C2 - 6103815

AN - SCOPUS:0018836810

VL - 63

SP - 159

EP - 166

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -